TABLE 1:
Inc protein (annotation/name) | Host cell protein targetsb | Proposed functions | References | ||
---|---|---|---|---|---|
Strain D/UW3 | Strain L2/434 | General | |||
CT005 | CTL0260 | IncV | VAPA/B | Formation of ER-inclusion MCS; non-vesicle lipid uptake by C. trachomatis. | [52, 59, 125, 189] |
CT006 | CTL0261 | - | Unknown | Unknown. | [59] |
CT101 | CTL0356 | MrcA | ITPR3 | Promotion of chlamydial extrusion; localize at inclusion microdomains. | [52, 128, 130] |
CT115 | CTL0370 | IncD | CERT | Formation of ER-inclusion MCS; non-vesicle lipid uptake by C. trachomatis. | [50, 51, 120] |
CT116 | CTL0371 | IncE | SNX5/6 | Modulation of retromer-dependent trafficking. | [50, 51, 59, 86–88] |
CT117 | CTL0372 | IncF | Unknown | Heterophilic Inc-Inc interactions. | [50, 51, 59, 75] |
CT118 | CTL0373 | IncG | 14-3-3β | Unknown; associates with LDs. | [50, 51, 145, 221] |
CT119 | CTL0374 | IncA | VAMP3/7/8 | Homotypic inclusion fusion; regulation of host cell vesicular trafficking; associates with LDs. | [8, 48, 50, 51, 69, 74, 77, 78, 189, 220] |
CT134 | CTL0389 | - | Unknown | Unknown. | [59] |
CT135 | CTL0390 | - | Unknown | Important for chlamydial virulence in a mouse infection model. | [59, 149, 150] |
CT147 | CTL0402 | - | Unknown | Unknown. | [50, 59, 65] |
CT179 | CTL0431 | - | Unknown | Unknown. | [59] |
CT192 | CTL0444 | - | Unknown | Unknown. | [59] |
CT222 | CTL0475 | - | Unknown | Heterophilic Inc-Inc interactions; localizes at inclusion microdomains. | [52, 59, 75, 128] |
CT223 | CTL0476 | IPAM | CEP170 | Modulation of the microtubule network; inhibition of host cell cytokinesis; localizes at inclusion microdomains. | [49, 50, 52, 59, 109, 133] |
CT224 | CTL0477 | - | Unknown | Inhibition of host cell cytokinesis; localizes at inclusion microdomains. | [52, 59, 133] |
CT225 | CTL0477A | - | Unknown | Inhibition of host cell cytokinesis. | [50, 52, 133] |
CT226 | CTL0478 | - | Unknown | Unknown. | [50, 52, 56, 59] |
CT227 | CTL0479 | - | Unknown | Unknown. | [52, 59] |
CT228 | CTL0480 | - | MYP1 | Inhibition of chlamydial extrusion; localizes at inclusion microdomains. | [50, 52, 138, 140] |
CT229 | CTL0481 | CpoS | RABs | Control of inclusion membrane stability and/or host cell death, and of host cell vesicular trafficking. | [49, 50, 52, 59, 96–98, 100] |
CT232 | CTL0484 | IncB | Unknown | Localizes at inclusion microdomains. | [50, 59, 128] |
CT233 | CTL0485 | IncC | Unknown | Control of inclusion membrane stability; localizes at inclusion microdomains. | [49, 50, 59, 100] |
CT249 | CTL500A | - | Unknown | Unknown. | [50, 52, 57] |
CT288 | CTL0540 | - | CCDC146 | Localizes at inclusion microdomains. | [49, 50, 59, 135] |
CT345 | CTL0599 | - | Unknown | Unknown. | [59] |
CT358 | CTL0612 | - | Unknown | Unknown. | [50] |
CT383 | CTL0639 | - | Unknown | Modulation of inclusion membrane stability. | [59, 100] |
CT440 | CTL0699 | - | Unknown | Unknown. | [50] |
CT442 | CTL0701 | CrpA | Unknown | Unknown. | [49, 50, 53, 59] |
CT449 | CTL0709 | - | Unknown | Unknown. | [59] |
CT483 | CTL0744 | - | Unknown | Unknown. | [52] |
CT565 | CTL0828 | - | Unknown | Unknown. | [52] |
CT618 | CTL0882 | - | Unknown | Associates with LDs. | [50, 54, 221] |
CT813 | CTL0184 | InaC | 14-3-3 proteins, ARF1/4, VAMP7/8 | Modulation of post-translational modification of microtubules, and of F-actin and Golgi redistribution around the inclusion. | [15, 50, 52, 55, 74, 112] |
CT850 | CTL0223 | - | DYNLT1 | Inclusion positioning at the centrosomal region; localizes at inclusion microdomains. | [52, 128] |
Proteins with the characteristic hydrophobic bilobal domain and which have been experimentally detected at the inclusion membrane. See list of abbreviations and main text for abbreviations and protein nomenclature, respectively.
Only interactions of C. trachomatis Incs (and not of Incs from other Chlamydia species) with host cell proteins were considered; while potential interactions between several C. trachomatis Incs and many human proteins have been described by large scale proteomics [85], only those further validated are specified in Table 1.